SPRY1 and Familial prostate cancer: In agreement with earlier studies showing upregulation of FGFs in prostate cancer, Kwabi-Adoo et al. concluded that Spry1 downregulation may lead to the unrestrained FGF-induced signal transduction and hence tumor progression.